Shares of Biodexa Pharmaceuticals skyrocketed nearly 50% on Monday, hitting their highest level since early December. The Cardiff, UK-based company's stock surge followed the U.S. FDA granting its ...
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.04%, China's Shanghai Composite Index ...
Biodexa (NASDAQ:BDRX) stock soared 76% in morning trading after the company announced it has received FDA Fast Track designation for its drug eRapa for the treatment of familial adenomatous polyposis, ...
European shares were higher today. The eurozone's STOXX 600 gained 0.5%, Germany's DAX 40 rose 0.6% and France's CAC 40 rose ...
This contract extension represents a milestone in the long-standing collaboration between Inspired and Moto Hospitality, built on trust, shared objectives, and a commitment to innovation. As part of ...
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a ...